Edito Medicine (EDIT) Fofon Wukun

Edito Medicine

Healthcare · USD · United States of America

Lekwuchon$2.59Aniis 25 Sep 2026 19:59 UTC

Change-6.16%

AI forecast: EDIT

1 day

🔒 Unlock Premium

1 week

🔒 Unlock Premium

1 month

🔒 Unlock Premium

AI akapichichin target price fowor next trading day, end of the week, ane end of the month. Change akapichichin fowor latest price. These are statistical estimates, not investment advice.

Price over the last 6 months

Premium e fannin na target-ka price ka AI an 1 raan, 1 uikku, 1 fawwun, fofon ane ekka fenn stock.

Unlock Premium

🔒 Rekord faan faanik

Rekord fowkas past — fowkas past kato-in kato-in fowkas akis — akis akis Premium.

Unlock Premium

Ettan An Company

Editas Medicine, Inc. is a biotechnology company that provides gene engineering services. The company develops genome editing technologies to create a platform for potential therapeutic agents and operates in the United States.

Stocks e fefan

TXG10X Genomics Inc Lekwuchon$85.71 +1.90%AI forecast · 1 day🔒 Premium

ABTAbbott Lekwuchon$101.31 +0.24%AI forecast · 1 day🔒 Premium

ABBVAbbVie Lekwuchon$264.31 -0.31%AI forecast · 1 day🔒 Premium

ABCLAbCellera Biologics Lekwuchon$12.72 +0.47%AI forecast · 1 day🔒 Premium

ACADACADIA Pharmaceuticals Inc Lekwuchon$20.68 -6.76%AI forecast · 1 day🔒 Premium

ACMRACM Research Inc Lekwuchon$77.34 +1.52%AI forecast · 1 day🔒 Premium

ADAPAdaptimmune Therapeutics АДР Lekwuchon$0.03 +50.00%AI forecast · 1 day🔒 Premium

ADPTAdaptive Biotechnologies Lekwuchon$29.45 -0.41%AI forecast · 1 day🔒 Premium

Get AI Stock Predictions Now

Download our app for AI stock forecasts on iPhone, Android and Windows

Unlock Premium

Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.